Nuclear medicine approaches in the monitoring of thyroid cancer patients

Journal of B.U.ON.

Volumn 11, Issue 4, 2006, Pages 511-518

  Sergieva, Sonia B ^a   Hadjieva, T ^b   Doldurova, M ^a   Stefanova, S ^a   Dudov, A ^a  

^a Sofia Cancer Centre   (Bulgaria)

^b UNIVERSITY HOSPITAL 'QUEEN GIOVANNA'   (Bulgaria)

Author keywords

131I whole body scan; 99mTc MIBI scintigraphy; Thyroglobulin; Thyroid cancer

Indexed keywords

IODINE 131; LEVOTHYROXINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THYROGLOBULIN; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE LESION; BRAIN DAMAGE; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; FOLLICULAR CARCINOMA; FOLLOW UP; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; PAPILLARY CARCINOMA; PAPILLOMA; PATIENT MONITORING; PLANAR CHROMATOGRAPHY; SENSITIVITY ANALYSIS; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROID SCINTISCANNING; THYROIDECTOMY; WHOLE BODY SCINTISCANNING; ADENOCARCINOMA; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; MIDDLE AGED; NECK; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE PLANNING; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NECK; PATIENT CARE PLANNING; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33947504260     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lind P. I-131 whole-body scintigraphy in thyroid cancer patients. Q J Nucl Med 1999; 43:188-194.
2. Pacini F, Cappezone M, Elisei R et al. Diagnostic 131-I whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endicrinol Metab 2002; 87:1499-1501.
3. Lind P. Should high s-Tg levels in the absence of iodine uptake be treated? Eur J Nucl Med 2003; 30:157-160.
4. Grosso M, Boni G, Bottoni A et al. Usefulness of 99mTc-Tetrofosmin scintigraphy and gamma-probe detection of node metastases of thyroid cancer. Eur J Nucl Med 2000; 27: p 1151, PS 561 (abstr).
5. Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;89;1447-1463.
6. Malesevic M, Stefanovic LJ. Value of 99mTc-MIBI scintigraphy in the follow-up of patients confirmed thyroid carcinoma. Eur J Nucl Med 2000; 27: p 1150, PS 560 (abstr).
7. Casara D, Rubello D, Mazzarotto R et al. Role of MIBI scan, neck US and s-Tg in clinical staging of differentiated thyroid carcinoma (DTC) patients after surgery. Eur J Nucl Med 2000; 27: p 1151, PS 562 (abstr).
8. Kabasakal L, Selcuk NA, Shafipour H et al. Treatment of iodine-negative, thyroglobuline-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases. Eur J Nucl Med Mol Imaging 2004; 31:1500-1504.
9. Schlumberger M, Baudin E. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma. Eur J Endocrinol 1998; 138: 249-252.
10. Rubello D, Mazzarotto R, Casare D et al. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery. Eur J Nucl Med 2000; 27: 431-440.
11. Tzonevska A, Chakalova A, Sergieva S et al. Comparative assessment of 131 I and 99mTc-MIBI imaging in the follow-up of patients with differentiated thyroid carcinoma after thyroidectomy. Hell J Nucl Med 2001; 4: 165-168.
12. Wu HS, Hseu HH, Lin WY et al. Decreased uptake after fractionated ablative doses of iodine-131. Eur J Nucl Med Mol Imaging 2005; 32:167-173.
13. Pineda JD, Lee T, Ain K et al. Iodine therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 1995; 80:1488-1492.
14. Biermann M., Schober O. Should high s-Tg levels in the absence of iodine uptake be treated? Against. Eur J Nucl Med 2003; 30:160-163.